Participate in Research

Browse Clinical Trials
The ALT-FLOW II Clinical Trial for Heart Failure Patients
Protocol: STUDY00008349
Full Title
A randomized, sham-controLled, clinical Trial For evaLuation Of the EdWards APTURE transcatheter shunt system (ALT-FLOW II)
Description
People diagnosed with chronic heart failure may be eligible for a new clinical trial. The goal of this study is to see if a new device (the APTURE system) can help to improve symptoms related to heart failure.

Participants will be enrolled in this study for about 5 years. Following a screening period, eligible participants will be randomly assigned (which happens by chance, like flipping a coin) to receive either the study device or a sham-procedure. They will complete follow-up appointments at 30 days, 3 months, 6 months, 1 year, and annually through 5 years. Throughout the study they will have physical exams, blood work, other lab tests, and complete surveys.

Participants will receive $50 for completing each in-person study visit.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
-Adults 18 years or older
-Have been diagnosed with heart failure
-Speak English
Age Group: Adults
Principal Investigator: VIJAY IYER
ClinicalTrials.gov: Open Study
Contact(s)
DAWN HOLLER
dlh68@buffalo.edu
+1 716-829-6115
COURTNEY BISHOP
cabishop@buffalo.edu

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login